The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 25, 2010
Filed:
Mar. 06, 2007
James F. Blake, Longmont, CO (US);
Steven Armen Boyd, Longmont, CO (US);
Jason DE Meese, Firestone, CO (US);
Kin Chiu Fong, Longmont, CO (US);
John J. Gaudino, Longmont, CO (US);
Tomas Kaplan, Broomfield, CO (US);
Allison L. Marlow, Louisville, CO (US);
Jeongbeob Seo, Broomfield, CO (US);
Allen A. Thomas, Louisville, CO (US);
Hongqi Tian, Longmont, CO (US);
Frederick Cohen, San Francisco, CA (US);
Wendy B. Young, San Mateo, CA (US);
James F. Blake, Longmont, CO (US);
Steven Armen Boyd, Longmont, CO (US);
Jason De Meese, Firestone, CO (US);
Kin Chiu Fong, Longmont, CO (US);
John J. Gaudino, Longmont, CO (US);
Tomas Kaplan, Broomfield, CO (US);
Allison L. Marlow, Louisville, CO (US);
Jeongbeob Seo, Broomfield, CO (US);
Allen A. Thomas, Louisville, CO (US);
Hongqi Tian, Longmont, CO (US);
Frederick Cohen, San Francisco, CA (US);
Wendy B. Young, San Mateo, CA (US);
Array BioPharma Inc., Boulder, CO (US);
Genentech, Inc., South San Francisco, CA (US);
Abstract
Compounds of Formulas Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.